Wu Jing,Deng Zhikuan,Zhao Jinghong,Huang Yunjian,Feng Bing.Impact of chronic kidney disease on patients’ cognitive function and its related factors: a preliminary study[J].J Amry Med Univ (J Third Mil Med Univ),2016,38(15):1773-1776.
Wu Jing,Deng Zhikuan,Zhao Jinghong,Huang Yunjian,Feng Bing.Impact of chronic kidney disease on patients’ cognitive function and its related factors: a preliminary study[J].J Amry Med Univ (J Third Mil Med Univ),2016,38(15):1773-1776.DOI:
Impact of chronic kidney disease on patients’ cognitive function and its related factors: a preliminary study
Objective To investigate the impact of chronic kidney disease (CKD) on patients’ cognitive function and its related factors. Methods A total of 266 patients diagnosed with 3-5 stage CKD
age 18 years
enrolled as outpatients or inpatients in our nephrology department from June 2014 to June 2015
were subjected this study. According to the value of estimated glomerular filtration rate (eGFR)
the patients were divided into stage 3 CKD group (CKD3) (60 mL/min>eGFR≥ 30 mL/min
n=92)
stage 4 CKD group (CKD4) (30 mL/min>eGFR≥ 15 mL/min
n=96) and stage 5 CKD group (CKD5) (eGFR 15 mL/min
n=78). Eighty cases of control were recruited from hospital staffs following the criteria: normal appearance
eGFR90 mL/min and matched age
sex
and education level with the patients. Mini-mental state examination (MMSE) was performed to evaluate the subjects’ cognitive function. The levels of serum creatinine (Cr)
urea nitrogen (UN)
uric acid (UA)
cholesterol (CHE)
high density lipoprotein cholesterol (HDL-C)
and low density lipoprotein cholesterol (LDL-C) were determined by OLYMPUS AU2700 automatic biochemical analyzer. Hemoglobin (Hb) level was examined by XFA9500 automatic blood cell analyzer. All data were analyzed using statistical software SSPS 13.0. Results The overall incidence of cognitive impairment in stage 3-5 CKD groups was remarkably higher (33.1%) than that of the control (7.5%). Moreover
the incidence of cognitive impairment was increased along the CKD stage from 3 to 5. In the CKD-4 and -5 groups the increased incidence was statistically significant (P0.01). In addition
the MMSE score was significantly decreased from stage 3 to 5 compared to the control (CKD 3 group
P0.05; CKD-4 and -5 groups
P0.01). The MMSE score was negatively correlated with the factors of age
UN
Cr and UA (P0.01)
but positively correlated with Hb (P0.05) and eGFR (P0.01). Conclusion CKD affects the patients’ cognitive function significantly. The incidence and severity of cognitive impairment are related closely with the levels of blood UN